Newsletters
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
WHO seeks experts for critical antibiotics advisory group
Dear All, WHO have opened a call for experts to be part of an Advisory Group on their Critically Important ...
Read More >
WHO 2020 clinical/preclinical pipeline review; Chat with WHO’s Peter Beyer
Dear All, WHO have today updated their 2019 clinical/preclinical pipeline review by releasing their 2020 analyses of both the clinical ...
Read More >
FDA-NIAID-CDC: Developing drugs for gonorrhea, 23 Apr 21 workshop
Dear All, FDA, NIAID and CDC have announced a public workshop on development considerations of antimicrobial drugs for the treatment ...
Read More >
Developing antibiotics for children: There are no easy answers
Aside: If you’ve enjoyed the prior discussions of movies to inspire antibiotic R&D and very apropos given the theme of today’s ...
Read More >
Vaccines to turn back the tide of antimicrobial resistance
Dear All, See also this related newsletter: 14 Jul 2022, entitled “WHO Vaccine Pipeline Review; CDC On Impact Of COVID ...
Read More >
Stewardship & Access Guide from CARB-X, Wellcome, and partners: Analysis, video chat
Dear All, Novel antibacterial agents, vaccines, and diagnostics will do little if they are not widely available and used responsibly. ...
Read More >
Amended Indian PPL slide / SUPERBUGS Act / Novo REPAIR Global Call
Dear All, Three bits of news you can use… First, when I wrote yesterday about the new Indian Priority Pathogen ...
Read More >
Where’s the innovation? / Indian Priority Pathogen List / DTR video explainer
Dear All, Three things briefly this evening: First, the observation about the limited degree of innovation across products in Phases ...
Read More >
Pew infographic: Antibiotic R&D needs economic incentives
Dear All, I hope you have been enjoying the excellent new pipeline analysis from Pew Trusts (10 Mar 2021 newsletter) ...
Read More >
Updated global antibacterial pipeline review from Pew Trusts
Dear All, Pew Charitable Trusts have released an excellent update to their long-running series of pipeline reviews. Here are the ...
Read More >
AMR Action Fund ($1b for P2-3): Video chat with new CEO! New committed funds!
Dear All, I’ve written before about the AMR Action Fund (9 Jul 2020 newsletter): In brief, it is ~$1b pledged by ...
Read More >
UK Antibiotic Subscription Pilot: Updates from a webinar
Dear All (and with thanks to Kevin Outterson for co-authoring), We’ve written and talked before from various perspectives about the ...
Read More >
Brilliant 5-minute video explainer of the AMR problem!
Dear All, Andrew Jack of the Financial Times (FT) has produced a superb 5-minute video explainer of the AMR challenge! ...
Read More >
Job with global impact: Director, CIDRAP Antimicrobial Stewardship Program
Dear All, Launched in 2016, the Antimicrobial Stewardship Program (ASP) at the Center for Infectious Disease Research and Policy (CIDRAP) ...
Read More >
Fabulous full-time AMR-focused leadership role at WHO! Apply now!
Dear All, Just now posted is an excellent opportunity to be a full-time Team Lead at WHO in the AMR ...
Read More >
New YouTube videos! Cost of R&D, Antibiotic value, and Lessons from COVID
Dear All, For those of you who enjoy listening to learn, here are some updates to recent newsletters that you ...
Read More >
JPIAMR call: 25m Euro for interventions to reduce/prevent AMR
Dear All, JPIAMR is today launching an international call entitled “One Health interventions to prevent or reduce the development and ...
Read More >
All-in cost of a new antibiotic from discovery to 10 years on market
Dear All (and with thanks to Kevin Krause for co-authoring this newsletter), The elements that contribute to the all-in cost ...
Read More >
FDA offers 2 fellowships and 3 RFPs! Endpoints, breakpoints, PROs & more!
Dear All, Our colleagues at FDA are planning some serious AMR-related research during 2021-22 with the following fellowships and RFPs. ...
Read More >
Sunday 10 Jan: UCSF-Stanford regulatory conference with FDA
Dear All, New on the meetings calendar today is the 10 Jan 2021 UCSF-Stanford Innovations in Regulatory Science Summit. Per the ...
Read More >
